Welcome, Guest
FAQ's  | Contact us  |   Careers  |  Open an Account  |  Site Map  |   Login    
   Regular Stock Purchase Plan (RSP Plan) – A disciplined and easy way to invest in the equity market. Click here
Markets
 

Equity

You are in Announcement
Equity News Equity Commentary Equity ResultsMarket Performance Announcement Other Market Announcement Todays Board Meetings Forth coming board Meetings Book Closure ADR Prices Name Changes News Ticker De-listed Companies Sectorial Indices FII Activity [Cr] Global Indices Knowledge Center
BSE Announcements Jun 30 2011
J.B.CHEMICAL
J. B. Chemicals launches a new domestic division J. B. Chemicals & Pharmaceuticals (JBCPL) has announced the launch of the new femident division catering to gynecology and dental products in its domestic formulations business.The gynecology and dental segments, at present has combined sales of about Rs 2000 crore with annual robust growth of about 16%. The company has launched this division with over 100 medical representatives and 15 products some of which are first of its kind in its respective segment. The company plans to increase medical representative strength in this division to 300 in about 2 years time. The company would locus both on urban and rural markets, which presents good growth opportunity. JBCPT is already well known among medical fraternity in these segments and launch of this dedicated division will help company strengthen its position in these segments as well as in the domestic market.

Source:
Capital marketss Disclaimer
  Mutual fund partners
  

Company Search

New Trading Platforms

  Insta Plus
  View Insta Plus Demo
   How to Login

Copyright©2010. All rights Reserved.
Equities: Equities transactions executed by Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 |BSE SEBI Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 | Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances/complaints please write to us at: grievance@rsec.co.in
This site is best viewed in 1024x768 and higher resolution.